Ignite Creation Date:
2025-12-25 @ 1:23 AM
Ignite Modification Date:
2026-01-06 @ 9:12 PM
Study NCT ID:
NCT03769493
Status:
COMPLETED
Last Update Posted:
2023-01-19
First Post:
2018-12-05
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Mobile After-Care Intervention to Support Post-Hospital Transition (MACS)
Sponsor:
Butler Hospital
Organization:
Study Overview
Official Title:
Mobile After-Care Support Intervention for Patients With Schizophrenia Following Hospitalization (MACS)
Status:
COMPLETED
Status Verified Date:
2022-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
MACS
Brief Summary:
This study examines the feasibility and acceptability of a mobile device-delivered app, called Mobile After-Care Support (MACS), to improve patients' coping and treatment adherence following a hospitalization related to their psychotic-spectrum disorder.
Detailed Description:
In the open trial, all participants will receive a study-developed app to be used on a mobile phone. This app will support the use of healthy coping skills post-hospitalization, as well as help participants adhere to their discharge treatment plan. This phase is intended to inform the feasibility and acceptability of the app in preparation for a future randomized controlled trial.
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
Secondary ID Infos
| Secondary ID | Type | Domain | Link | View |
|---|---|---|---|---|
| R34MH115144 | NIH | None | https://reporter.nih.gov/quic… | View |